Skip to content
Search

Latest Stories

Boots transfers £4.8 Billion Pension Plan to Legal & General

Boots transfers £4.8 Billion Pension Plan to Legal & General

Boots also brings in an additional payment of around £500m to the scheme

Walgreens Boots Alliance (WBA), which owns the retail pharmacy chain Boots in the UK, has signed a buy-in deal with financial services company Legal & General, transferring its £4.8 billion ($6 billion) pension plan to the latter.


In a release issued on Friday, the company said that the deal is the “largest single transaction of its kind,” in the UK and insures all 53,000 members in the Boots Pension Scheme.

The company said it was the best options to “safeguard members’ benefit against market uncertainty, improved life expectancies and other risks”.

Boots is also bringing in an additional payment of around £500m to the scheme, in addition to the sum (£170m) it has already committed.

Boots Pension Scheme trustee chair Alan Baker is optimistic that this agreement with Legal & General will give “added protection to our members’ long-term benefits by removing market uncertainty and other financial exposures.”

"The scheme will not be reliant on Boots to pay benefits to members and pensions will be protected for decades to come," he added.

L&G will assume the responsibility for issuing individual annuity policies to scheme members and paying benefits directly to them.

However, the business said will take up to two years to complete the process of moving the members, after which it will bear most of the scheme’s economic risk.

Boots UK managing director Seb James commented that they “have fully secured the benefits of all members with a highly respected insurer” and this will provide “greater certainty to both the scheme members and to Boots and is an excellent outcome for both parties."

Describing the deal as their “largest ever single transaction”, Legal & General CEO Kail said it was a proof to their “long-standing relationship with the client.

Earlier, the WBA had agreed to guarantee the scheme but the agreement has been terminated and replaced with a smaller, temporary guarantee.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less